Cipla Quality Chemical Industries Ltd (CiplaQCIL) has extended by two business days, the Retail Offer period published in the Prospectus relating to the Initial Public Offering.
This was at the request of the Capital Markets Authority and in order to accommodate the public holiday on 21st August 2018, according to a Press Statement that was issued by the company.
“Now, as such, the Retail Offer Closing Date has changed from Friday, 24th August 2018 to Tuesday, 28th August 2018,” the statement indicated.
CiplaQCIL is a state-of-the-art pharmaceutical plant based in Kampala, Uganda and focused on production of high-quality, World Health Organization (WHO) pre-qualified, life-saving medicines for the Sub-Saharan Africa (SSA) region.
The Company’s products and pipeline target four major diseases that are widespread in Uganda and SSA and comprise anti-malarials, anti-retrovirals and Hepatitis B and C drugs.
CiplaQCIL’s relevant products have been prequalified by WHO and the facility has been approved by regulatory authorities in the following countries: Uganda, Kenya, Tanzania, Namibia, Zambia, Angola, Malawi, Mozambique, Ivory Coast, Ethiopia, Ghana, Zimbabwe and Botswana.